Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".

Abdelmaksoud, Ayman; Goldust, Mohamad; Vestita, Michelangelo

Abdelmaksoud, Ayman; Goldust, Mohamad; Vestita, Michelangelo.

Abdelmaksoud A; Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
Goldust M; Department of Dermatology, University of Rome G. Marconi, Rome, Italy.
Vestita M; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.

Dermatol Ther ; 33(4): e13360, 2020 07.

Article in English | MEDLINE | ID: covidwho-27951

Subject(s)

Coronavirus Infections; Immunosuppressive Agents; Pandemics; Pneumonia, Viral; Psoriasis; Betacoronavirus; COVID-19; Humans; Immunosuppressive Agents/adverse effects; Psoriasis/diagnosis; Psoriasis/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Psoriasis / Coronavirus Infections / Pandemics / Immunosuppressive Agents Type of study: Diagnostic study Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.13360

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google